Project Grant HT94252410790
Award Date
7/15/24
Completion Date
7/14/27
Dollars Obligated
$663K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Belgium
Similar Awards
The U.S. Defense Health Agency has awarded a $602,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Vlaams Instituut Voor Biotechnologie (VIB), a non-profit research institute in Belgium. The grant, effective September 1, 2024 through August 31, 2027, will fund VIB's research on a "Reduced Combination of Genetic Variants to Predict and Stratify Alzheimer's Disease." This project aims to advance medical solutions for neurodegenerative...
The Department of the Army Medical Command awarded a $1,035,468 project grant to the Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology (VIB) under the Military Medical Research and Development program (CFDA 12.420). The four-year award beginning September 1, 2021 will support the development of innovative proteomics approaches to identify fluid biomarkers for frontotemporal degeneration. Through this funding, VIB will conduct research to investigate medical solutions...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
The Department of the Air Force awarded Universiteit Gent (Ugent), a non-profit organization in Belgium, a $160,000.00 Project Grant under the Air Force Defense Research Sciences Program (CFDA 12.800). The grant provides funding from September 1, 2023 to August 31, 2025 for research and development in the area of electrical engineering. As a prime recipient, Ugent has conducted federally funded R&D for the U.S. government in various scientific fields, including physics, geology, and the...
The Department of the Army Medical Command awarded a $1,045,068 project grant under the Military Medical Research and Development program to the Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology. The grant will fund an innovative proteomics approach to identify fluid biomarkers for frontotemporal degeneration from September 1, 2021 to August 31, 2025. Through this funding, the Vlaams Instituut Voor Biotechnologie will apply proteomics techniques to analyze bodily fluids...
Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...